INS and metabolic dysfunction-associated steatohepatitis: Comparing MASH patients to control participants matched for body mass index and insulin resistance revealed that alterations in bile salt concentrations were associated with insulin resistance rather than liver inflammation highlighting the interaction between insulin signaling and bile salts [43].